Cantor Fitzgerald downgraded Pernix Therapeutics (NASDAQ: PTX) from Hold to Sell with a price target of $2.50, saying they are ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE